Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer
Condition(s):Head and Neck CancerLast Updated:April 16, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Head and Neck CancerLast Updated:April 16, 2019Completed
Condition(s):Colorectal CancerLast Updated:May 16, 2017Completed
Condition(s):Colorectal CancerLast Updated:February 12, 2021Completed
Condition(s):Pancreatic CancerLast Updated:March 20, 2017Completed
Condition(s):Colorectal CancerLast Updated:August 25, 2022Completed
Condition(s):Advanced or Recurrent Colorectal CancerLast Updated:April 6, 2017Completed
Condition(s):Head and Neck Squamous Cell Carcinoma; Squamous Cell Carcinoma of the Head and Neck (SCCHN); Head and Neck CancerLast Updated:November 10, 2022Completed
Condition(s):Advanced Colorectal CancerLast Updated:June 7, 2021Terminated
Condition(s):Pancreas CancerLast Updated:July 19, 2023Suspended
Condition(s):Solid TumorsLast Updated:May 18, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.